Home » Authors » James Etheridge

Articles by James Etheridge

Transgene In Line For €10M Milestone On CIN Compound

June 6, 2007

By James Etheridge

Pharmaxon Obtains Mimetic Peptide For Cell Mobility Drugs

June 6, 2007

By James Etheridge

Pharmaxon Obtains Mimetic Peptide For Cell Mobility Drugs

June 6, 2007

By James Etheridge

Transgene In Line For €10M Milestone On CIN Compound

June 6, 2007

By James Etheridge

No Abstract

Cellectis Reaches Milestone In Bayer CropScience Deal

May 30, 2007

By James Etheridge

BT Pharma Raises €1.3M To Advance ProCervix

May 30, 2007

By James Etheridge

BT Pharma Raises €1.3M To Advance ProCervix

May 30, 2007

By James Etheridge

No Abstract

Cellectis Reaches Milestone In Bayer CropScience Deal

May 30, 2007

By James Etheridge

Eurofins Scientific Opening Labs In Colorado, Singapore

May 16, 2007

By James Etheridge

Cellectis Licenses Technology For Homologous Recombination

May 16, 2007

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...